The California and San Francisco Departments of Public Health have confirmed the first case of the omicron variant in the United States in an individual in California who was fully vaccinated against COVID-19 and returned Nov. 22 from South Africa, the Centers for Disease Control and Prevention announced today. The individual had mild symptoms that are improving and is self-quarantining. All of the individual’s close contacts have been contacted and tested negative, CDC said. 

The World Health Organization Nov. 24 named Omicron a new variant of concern. The variant was first reported in South Africa. President Biden has ordered additional air travel restrictions for travelers to the U.S. from South Africa and seven other countries in Africa, which took effect Nov. 29. 

“CDC has been actively monitoring and preparing for this variant, and we will continue to work diligently with other U.S. and global public health and industry partners to learn more,” the agency said. It said the emergence of the new variant “further emphasizes the importance of vaccination, boosters, and general prevention strategies” to protect against COVID-19. 
 

Related News Articles

Headline
The Senate Finance Committee Feb. 4 voted 14-13 to advance Robert F. Kennedy Jr.’s nomination for secretary of the Department of Health and Human Services. A…
Headline
Respiratory illness activity remains high across the country, according to the latest data from the Centers for Disease Control and Prevention. Seasonal flu…
Headline
The Occupational Safety and Health Administration Jan. 13 announced that it terminated efforts to establish a final COVID-19 safety standard to protect workers…
Headline
The Department of Health and Human Services Dec. 10 amended the Public Readiness and Emergency Preparedness Act declaration for COVID-19, extending liability…
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…
Headline
The Centers for Disease Control and Prevention last week endorsed a recommendation for people aged 65 and older and for immunocompromised individuals to…